Literature DB >> 23949303

Effect of caloric restriction and AMPK activation on hepatic nuclear receptor, biotransformation enzyme, and transporter expression in lean and obese mice.

Supriya R Kulkarni1, Jialin Xu, Ajay C Donepudi, Wei Wei, Angela L Slitt.   

Abstract

PURPOSE: Fatty liver alters liver transporter expression. Caloric restriction (CR), the recommended therapy to reverse fatty liver, increases Sirtuin1 deacetylase activity in liver. This study evaluated whether CR and CR mimetics reversed obesity-induced transporter expression in liver and hepatocytes.
METHODS: mRNA and protein expression was determined in adult lean (lean) and leptin-deficient obese (OB) mice fed ad libitum or placed on 40% (kCal) reduced diet. Hepatocytes were isolated from lean and OB mice, treated with AMP Kinase activators, and gene expression was determined.
RESULTS: CR decreased Oatp1a1, Oatp1b2, and Abcb11 mRNA expression in lean, but not OB mice. CR increased Abcc2 mRNA OB livers, whereas protein expression increased in both genotypes. CR increased Abcc3 protein expression increased in OB livers. CR did not alter Abcc1, 4 and 5 mRNA expression in lean mice but decreased expression in livers of OB mice. CR increased Abcc4 protein in lean, but not OB mice.
CONCLUSIONS: CR restriction reversed the expression of some, but not all transporters in livers of OB mice. Overall, these data indicate a potential for CR to restore some hepatic transporter changes in OB mice, but suggest a functional leptin axis is needed for reversal of expression for some transporters.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23949303      PMCID: PMC4225720          DOI: 10.1007/s11095-013-1140-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  65 in total

1.  Energy restriction does not compensate for the reduced expression of hepatic drug-processing genes in mice with aging.

Authors:  Yu-Kun Jennifer Zhang; Kurt W Saupe; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2010-04-09       Impact factor: 3.922

2.  Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.

Authors:  Sarah J Schrieber; Roy L Hawke; Zhiming Wen; Philip C Smith; K Rajender Reddy; Abdus S Wahed; Steven H Belle; Nezam H Afdhal; Victor J Navarro; Catherine M Meyers; Edward Doo; Michael W Fried
Journal:  Drug Metab Dispos       Date:  2011-08-24       Impact factor: 3.922

Review 3.  PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

4.  SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.

Authors:  Xiuyun Hou; Shanqin Xu; Karlene A Maitland-Toolan; Kaori Sato; Bingbing Jiang; Yasuo Ido; Fan Lan; Kenneth Walsh; Michel Wierzbicki; Tony J Verbeuren; Richard A Cohen; Mengwei Zang
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

5.  Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway.

Authors:  Jonathan M Maher; Matthew Z Dieter; Lauren M Aleksunes; Angela L Slitt; Grace Guo; Yuji Tanaka; George L Scheffer; Jefferson Y Chan; Jose E Manautou; Ying Chen; Timothy P Dalton; Masayuki Yamamoto; Curtis D Klaassen
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

6.  NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis.

Authors:  Soona Shin; Nobunao Wakabayashi; Vikas Misra; Shyam Biswal; Gum Hwa Lee; Elin S Agoston; Masayuki Yamamoto; Thomas W Kensler
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

7.  Effects of caloric restriction on the kinetics of indocyanine green in patients with liver diseases and in the rat.

Authors:  H Ohkubo; H Musha; K Okuda
Journal:  Am J Dig Dis       Date:  1978-11

Review 8.  Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues.

Authors:  Marcella Fulco; Vittorio Sartorelli
Journal:  Cell Cycle       Date:  2008-12-09       Impact factor: 4.534

9.  Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver.

Authors:  Franck Rencurel; Marc Foretz; Michel R Kaufmann; Deborah Stroka; Renate Looser; Isabelle Leclerc; Gabriela da Silva Xavier; Guy A Rutter; Benoit Viollet; Urs A Meyer
Journal:  Mol Pharmacol       Date:  2006-09-20       Impact factor: 4.436

10.  Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice.

Authors:  Vijay R More; Xia Wen; Paul E Thomas; Lauren M Aleksunes; Angela L Slitt
Journal:  Comp Hepatol       Date:  2012-04-23
View more
  4 in total

1.  Dynamic Contrast-Enhanced MRI of OATP Dysfunction in Diabetes.

Authors:  Dorela D Shuboni-Mulligan; Maciej Parys; Barbara Blanco-Fernandez; Christiane L Mallett; Regina Schnegelberger; Marilia Takada; Shatadru Chakravarty; Bruno Hagenbuch; Erik M Shapiro
Journal:  Diabetes       Date:  2018-11-28       Impact factor: 9.461

2.  Intermittent Starvation Extends the Functional Lifetime of Primary Human Hepatocyte Cultures.

Authors:  Matthew D Davidson; Salman R Khetani
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

3.  Bisphenol A sulfonation is impaired in metabolic and liver disease.

Authors:  Emine B Yalcin; Supriya R Kulkarni; Angela L Slitt; Roberta King
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-19       Impact factor: 4.219

4.  Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK.

Authors:  Jozaa Z ALTamimi; Ghedeir M Alshammari; Nora A AlFaris; Reham I Alagal; Dalal H Aljabryn; Norah A Albekairi; Mahmoud Ahmad Alkhateeb; Mohammed Abdo Yahya
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.